Gurbani, Saumya S <br/><br/>
Assessing Treatment Response of Glioblastoma to an HDAC Inhibitor Using Whole-Brain Spectroscopic MRI.  [electronic resource] 

 -  Tomography (Ann Arbor, Mich.)  03 2019 
 - 53-60 p.  digital 
<br/><br/> Publication Type: Controlled Clinical Trial; Journal Article; Research Support, N.I.H., Extramural 
<br/><br/><label>ISSN: </label>2379-139X 
<br/><br/><label>Standard No.: </label>10.18383/j.tom.2018.00031  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adult<br/>Aged<br/>Animals<br/>Antidepressive Agents--administration & dosage<br/>Antineoplastic Agents--administration & dosage<br/>Behavior, Animal--drug effects<br/>Brain Neoplasms--diagnostic imaging<br/>Depression--drug therapy<br/>Dose-Response Relationship, Drug<br/>Female<br/>Glioblastoma--diagnostic imaging<br/>Histone Deacetylase Inhibitors--administration & dosage<br/>Humans<br/>Hydroxamic Acids--administration & dosage<br/>Kaplan-Meier Estimate<br/>Magnetic Resonance Imaging--methods<br/>Male<br/>Middle Aged<br/>Neoplasm Transplantation<br/>Pilot Projects<br/>Rats, Inbred F344<br/>Sulfonamides--administration & dosage<br/>Treatment Outcome<br/>Tumor Cells, Cultured